Integra LifeSciences Holdings Corporation IART
IART
Integra LifeSciences Holdings Corporation TNDM
Tandem Diabetes Care, Inc. PACB
Pacific Biosciences of California, Inc. MRVI
Maravai LifeSciences Holdings, Inc. SEPN
Septerna, Inc. FTRE
Fortrea Holdings Inc. MYGN
Myriad Genetics, Inc. BCAX
Bicara Therapeutics Inc. Common Stock EYPT
EyePoint Pharmaceuticals, Inc. INMD
InMode Ltd.
Integra LifeSciences Holdings Corporation TNDM
Tandem Diabetes Care, Inc. PACB
Pacific Biosciences of California, Inc. MRVI
Maravai LifeSciences Holdings, Inc. SEPN
Septerna, Inc. FTRE
Fortrea Holdings Inc. MYGN
Myriad Genetics, Inc. BCAX
Bicara Therapeutics Inc. Common Stock EYPT
EyePoint Pharmaceuticals, Inc. INMD
InMode Ltd.
Performance
| Periode | IART | TNDM | PACB | MRVI | SEPN | FTRE | MYGN | BCAX | EYPT | INMD |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 10.40 % | 3.08 % | 76.67 % | 69.25 % | 150.44 % | 165.99 % | 43.44 % | 70.66 % | 77.02 % | 8.76 % |
| YTD | -41.68 % | -40.29 % | 17.78 % | -34.34 % | 19.30 % | -15.71 % | -46.56 % | 9.27 % | 99.07 % | -14.33 % |
| 1Y | -44.13 % | -34.48 % | 8.16 % | -36.42 % | 13.76 % | -21.40 % | -50.00 % | 5.71 % | 114.28 % | -20.43 % |
| 3Y | -77.09 % | -48.16 % | -77.73 % | -74.74 % | 19.02 % | -50.88 % | -58.77 % | -20.97 % | 445.56 % | -61.49 % |
| 5Y | -76.66 % | -77.00 % | -89.86 % | -85.99 % | 19.02 % | -50.88 % | -60.96 % | -20.97 % | 252.87 % | -38.17 % |
| 10Y | -57.84 % | -81.96 % | -78.80 % | -87.92 % | 19.02 % | -50.88 % | -83.08 % | -20.97 % | -54.46 % | 113.99 % |
| From the beginning | 190.27 % | -88.89 % | -87.10 % | -87.92 % | 19.02 % | -50.88 % | 34.11 % | -20.97 % | -96.02 % | 113.99 % |